Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib

D. Kahraman; A. Holstein; M. Scheffler; T. Zander; L. Nogova; A.A. Lammertsma; R. Boellaard; B. Neumaier; M. Dietlein; J. Wolf; C. Kobe

doi:https://doi.org/10.1097/RLU.0b013e3182639747

Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib

D. Kahraman, A. Holstein, M. Scheffler, T. Zander, L. Nogova, A.A. Lammertsma, R. Boellaard, B. Neumaier, M. Dietlein, J. Wolf, C. Kobe

Radiology and Nuclear Medicine (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

47 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1058-1064
Journal	Clinical nuclear medicine
Volume	37
Issue number	11
DOIs	https://doi.org/10.1097/RLU.0b013e3182639747
Publication status	Published - 2012

Access to Document

https://doi.org/10.1097/RLU.0b013e3182639747

Cite this

Kahraman, D., Holstein, A., Scheffler, M., Zander, T., Nogova, L., Lammertsma, A. A., Boellaard, R., Neumaier, B., Dietlein, M., Wolf, J., & Kobe, C. (2012). Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib. Clinical nuclear medicine, 37(11), 1058-1064. https://doi.org/10.1097/RLU.0b013e3182639747

@article{bdd0f1faaf4e4fe9b6aaf111cbbade72,

title = "Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib",

author = "D. Kahraman and A. Holstein and M. Scheffler and T. Zander and L. Nogova and A.A. Lammertsma and R. Boellaard and B. Neumaier and M. Dietlein and J. Wolf and C. Kobe",

year = "2012",

doi = "https://doi.org/10.1097/RLU.0b013e3182639747",

language = "Undefined/Unknown",

volume = "37",

pages = "1058--1064",

journal = "Clinical nuclear medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "11",

}

Kahraman, D, Holstein, A, Scheffler, M, Zander, T, Nogova, L, Lammertsma, AA , Boellaard, R, Neumaier, B, Dietlein, M, Wolf, J & Kobe, C 2012, 'Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib', Clinical nuclear medicine, vol. 37, no. 11, pp. 1058-1064. https://doi.org/10.1097/RLU.0b013e3182639747

Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib. / Kahraman, D.; Holstein, A.; Scheffler, M. et al.
In: Clinical nuclear medicine, Vol. 37, No. 11, 2012, p. 1058-1064.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Tumor Lesion Glycolysis and Tumor Lesion Proliferation for Response Prediction and Prognostic Differentiation in Patients With Advanced Non-Small Cell Lung Cancer Treated With Erlotinib

AU - Kahraman, D.

AU - Holstein, A.

AU - Scheffler, M.

AU - Zander, T.

AU - Nogova, L.

AU - Lammertsma, A.A.

AU - Boellaard, R.

AU - Neumaier, B.

AU - Dietlein, M.

AU - Wolf, J.

AU - Kobe, C.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1097/RLU.0b013e3182639747

DO - https://doi.org/10.1097/RLU.0b013e3182639747

M3 - Article

C2 - 23027207

SN - 0363-9762

VL - 37

SP - 1058

EP - 1064

JO - Clinical nuclear medicine

JF - Clinical nuclear medicine

IS - 11

ER -